These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

936 related items for PubMed ID: 27714481

  • 1. TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes.
    Andrade RC, Dos Santos AC, de Aguirre Neto JC, Nevado J, Lapunzina P, Vargas FR.
    Fam Cancer; 2017 Apr; 16(2):243-248. PubMed ID: 27714481
    [Abstract] [Full Text] [Related]

  • 2. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.
    Giacomazzi J, Selistre SG, Rossi C, Alemar B, Santos-Silva P, Pereira FS, Netto CB, Cossio SL, Roth DE, Brunetto AL, Zagonel-Oliveira M, Martel-Planche G, Goldim JR, Hainaut P, Camey SA, Ashton-Prolla P.
    Cancer; 2013 Dec 15; 119(24):4341-9. PubMed ID: 24122735
    [Abstract] [Full Text] [Related]

  • 3. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
    Ruijs MW, Verhoef S, Rookus MA, Pruntel R, van der Hout AH, Hogervorst FB, Kluijt I, Sijmons RH, Aalfs CM, Wagner A, Ausems MG, Hoogerbrugge N, van Asperen CJ, Gomez Garcia EB, Meijers-Heijboer H, Ten Kate LP, Menko FH, van 't Veer LJ.
    J Med Genet; 2010 Jun 15; 47(6):421-8. PubMed ID: 20522432
    [Abstract] [Full Text] [Related]

  • 4. The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families.
    Achatz MI, Olivier M, Le Calvez F, Martel-Planche G, Lopes A, Rossi BM, Ashton-Prolla P, Giugliani R, Palmero EI, Vargas FR, Da Rocha JC, Vettore AL, Hainaut P.
    Cancer Lett; 2007 Jan 08; 245(1-2):96-102. PubMed ID: 16494995
    [Abstract] [Full Text] [Related]

  • 5. Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families.
    Varley JM, McGown G, Thorncroft M, Santibanez-Koref MF, Kelsey AM, Tricker KJ, Evans DG, Birch JM.
    Cancer Res; 1997 Aug 01; 57(15):3245-52. PubMed ID: 9242456
    [Abstract] [Full Text] [Related]

  • 6. Analysis of Li-Fraumeni syndrome and Li-Fraumeni-like families for germline mutations in Bcl10.
    Stone JG, Eeles RA, Sodha N, Murday V, Sheriden E, Houlston RS.
    Cancer Lett; 1999 Dec 01; 147(1-2):181-5. PubMed ID: 10660104
    [Abstract] [Full Text] [Related]

  • 7. The TP53 mutational spectrum and frequency of CHEK2*1100delC in Li-Fraumeni-like kindreds.
    Siddiqui R, Onel K, Facio F, Nafa K, Diaz LR, Kauff N, Huang H, Robson M, Ellis N, Offit K.
    Fam Cancer; 2005 Dec 01; 4(2):177-81. PubMed ID: 15951970
    [Abstract] [Full Text] [Related]

  • 8. A novel TP53 germline inframe deletion identified in a Spanish series of Li-fraumeni syndrome suspected families.
    Llovet P, Illana FJ, Martín-Morales L, de la Hoya M, Garre P, Ibañez-Royo MD, Pérez-Segura P, Caldés T, García-Barberán V.
    Fam Cancer; 2017 Oct 01; 16(4):567-575. PubMed ID: 28573494
    [Abstract] [Full Text] [Related]

  • 9. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.
    Olivier M, Goldgar DE, Sodha N, Ohgaki H, Kleihues P, Hainaut P, Eeles RA.
    Cancer Res; 2003 Oct 15; 63(20):6643-50. PubMed ID: 14583457
    [Abstract] [Full Text] [Related]

  • 10. Clinical spectrum of Li-Fraumeni syndrome/Li-Fraumeni-like syndrome in Brazilian individuals with the TP53 p.R337H mutation.
    Ferreira AM, Brondani VB, Helena VP, Charchar HLS, Zerbini MCN, Leite LAS, Hoff AO, Latronico AC, Mendonca BB, Diz MDPE, de Almeida MQ, Fragoso MCBV.
    J Steroid Biochem Mol Biol; 2019 Jun 15; 190():250-255. PubMed ID: 30974190
    [Abstract] [Full Text] [Related]

  • 11. Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry.
    Yurgelun MB, Masciari S, Joshi VA, Mercado RC, Lindor NM, Gallinger S, Hopper JL, Jenkins MA, Buchanan DD, Newcomb PA, Potter JD, Haile RW, Kucherlapati R, Syngal S, Colon Cancer Family Registry.
    JAMA Oncol; 2015 May 15; 1(2):214-21. PubMed ID: 26086041
    [Abstract] [Full Text] [Related]

  • 12. p53 signaling pathway polymorphisms, cancer risk and tumor phenotype in TP53 R337H mutation carriers.
    Macedo GS, Vieira IA, Vianna FSL, Alemar B, Giacomazzi J, Brandalize APC, Caleffi M, Volc SM, de Campos Reis Galvão H, Palmero EI, Achatz MI, Ashton-Prolla P.
    Fam Cancer; 2018 Apr 15; 17(2):269-274. PubMed ID: 28756477
    [Abstract] [Full Text] [Related]

  • 13. The profile and contribution of rare germline copy number variants to cancer risk in Li-Fraumeni patients negative for TP53 mutations.
    Silva AG, Krepischi AC, Pearson PL, Hainaut P, Rosenberg C, Achatz MI.
    Orphanet J Rare Dis; 2014 Apr 28; 9():63. PubMed ID: 24775443
    [Abstract] [Full Text] [Related]

  • 14. Next generation sequencing is informing phenotype: a TP53 example.
    O'Shea R, Clarke R, Berkley E, Giffney C, Farrell M, O'Donovan E, Gallagher DJ.
    Fam Cancer; 2018 Jan 28; 17(1):123-128. PubMed ID: 28509937
    [Abstract] [Full Text] [Related]

  • 15. Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients.
    Lee DS, Yoon SY, Looi LM, Kang P, Kang IN, Sivanandan K, Ariffin H, Thong MK, Chin KF, Mohd Taib NA, Yip CH, Teo SH.
    Breast Cancer Res; 2012 Apr 16; 14(2):R66. PubMed ID: 22507745
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Rare germline variant (rs78378222) in the TP53 3' UTR: Evidence for a new mechanism of cancer predisposition in Li-Fraumeni syndrome.
    Macedo GS, Araujo Vieira I, Brandalize AP, Giacomazzi J, Inez Palmero E, Volc S, Rodrigues Paixão-Côrtes V, Caleffi M, Silva Alves M, Achatz MI, Hainaut P, Ashton-Prolla P.
    Cancer Genet; 2016 Mar 16; 209(3):97-106. PubMed ID: 26823150
    [Abstract] [Full Text] [Related]

  • 18. The TP53 gene promoter is not methylated in families suggestive of Li-Fraumeni syndrome with no germline TP53 mutations.
    Finkova A, Vazna A, Hrachovina O, Bendova S, Prochazkova K, Sedlacek Z.
    Cancer Genet Cytogenet; 2009 Aug 16; 193(1):63-6. PubMed ID: 19602465
    [Abstract] [Full Text] [Related]

  • 19. Association of germline or somatic TP53 missense mutation with oncogene amplification in tumors developed in patients with Li-Fraumeni or Li-Fraumeni-like syndrome.
    Sugawara W, Arai Y, Kasai F, Fujiwara Y, Haruta M, Hosaka R, Nishida K, Kurosumi M, Kobayashi Y, Akagi K, Kaneko Y.
    Genes Chromosomes Cancer; 2011 Jul 16; 50(7):535-45. PubMed ID: 21484931
    [Abstract] [Full Text] [Related]

  • 20. TP53 germline mutations in adult patients with adrenocortical carcinoma.
    Herrmann LJ, Heinze B, Fassnacht M, Willenberg HS, Quinkler M, Reisch N, Zink M, Allolio B, Hahner S.
    J Clin Endocrinol Metab; 2012 Mar 16; 97(3):E476-85. PubMed ID: 22170717
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.